TNF-α increases lipogenesis via JNK and PI3K/Akt pathways in SZ95 human sebocytes

J Dermatol Sci. 2012 Mar;65(3):179-88. doi: 10.1016/j.jdermsci.2011.11.005. Epub 2011 Nov 20.

Abstract

Background: Tumor necrosis factor-alpha (TNF-α) is an important pathophysiologic factor involved in the development of acne. However, its role is unclear.

Objective: To explore the lipogenic effect by TNF-α and possible molecular mechanisms in sebocyte.

Methods: Using SZ95 human sebocytes, lipid formation by TNF-α was assessed by Oil Red O, Nile Red staining and thin layer chromatography (TLC). Expression of lipogenic genes and activation of mitogen-activated protein kinase as well as Akt were examined by real-time polymerase chain reaction and/or Western blot analysis. Activation of peroxisome proliferator-activated receptor (PPAR) was evaluated by luciferase assay using PPAR response element containing reporter plasmids. Involvement of c-Jun N-terminal kinase (JNK) and Akt in TNF-α-induced lipogenesis was investigated by molecule specific small interfering RNA and inhibitors.

Results: TNF-α treatment significantly increased formation of lipid droplets in accordance with up-regulated expression of FAS and activation of SREBP-1, but not PPARs. Suppression of phosphorylated JNK by the JNK inhibitor SP600125 greatly diminished TNF-α-induced expression of FAS and SREBP-1. TNF-α could not induce both expression of lipogenic proteins and lipid synthesis when Akt expression was attenuated with siRNA.

Conclusions: TNF-α induces lipogenesis in SZ95 human sebocytes through the JNK and phosphoinositide-3-kinase/Akt pathways. These results will be valuable in developing therapeutic strategies for control of seborrhea and acne.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Humans
  • Lipid Metabolism / drug effects
  • Lipogenesis / drug effects*
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology*
  • Peroxisome Proliferator-Activated Receptors / drug effects
  • Peroxisome Proliferator-Activated Receptors / physiology
  • Phosphatidylinositol 3-Kinases / drug effects
  • Phosphatidylinositol 3-Kinases / physiology*
  • Proto-Oncogene Proteins c-akt / drug effects
  • Proto-Oncogene Proteins c-akt / physiology*
  • Sebaceous Glands / cytology*
  • Sebaceous Glands / drug effects
  • Sebaceous Glands / metabolism
  • Signal Transduction / drug effects*
  • Signal Transduction / physiology
  • Sterol Regulatory Element Binding Protein 1 / physiology
  • Tumor Necrosis Factor-alpha / pharmacology*
  • fas Receptor / drug effects
  • fas Receptor / physiology

Substances

  • Peroxisome Proliferator-Activated Receptors
  • SREBF1 protein, human
  • Sterol Regulatory Element Binding Protein 1
  • Tumor Necrosis Factor-alpha
  • fas Receptor
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt